Company intelligence / Profile preview
Guardian Therapeutics
Lexington, MA, United Statesguardiantherapeutics.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Guardian Therapeutics is developing engineered aptamer-based therapeutics targeting significant unmet medical needs across multiple therapeutic areas. The company’s lead programs focus on disrupting protein-protein interactions for therapeutic benefit. Clinical results have not been publicly detailed as of the latest available information.[2][3]
- Therapeutic areas
- OncologyHematologyDermatologyGastroenterologyInfectious Diseases
- Modalities
- Aptamers (engineered drug-like aptamers)[2][3][6]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Collaborations and partnerships with established biopharma companies are planned but specific partners are not named in public sources.[6]
Beyond the preview
Go deeper on Guardian Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guardian Therapeutics.